US4572908A
(en)
*
|
1982-12-21 |
1986-02-25 |
Pfizer Inc. |
Dihydropyridines
|
GB8306666D0
(en)
*
|
1983-03-10 |
1983-04-13 |
Pfizer Ltd |
Therapeutic agents
|
EP0125803A3
(en)
*
|
1983-04-27 |
1987-01-21 |
FISONS plc |
Pharmaceutically active dihydropyridines
|
EP0168841B1
(en)
*
|
1983-12-19 |
1988-09-28 |
Pfizer Limited |
Dihydropyridine intermediate
|
JPS60156671A
(ja)
*
|
1984-01-25 |
1985-08-16 |
Yamanouchi Pharmaceut Co Ltd |
ジヒドロピリジン誘導体およびその製造法
|
GB8414518D0
(en)
*
|
1984-06-07 |
1984-07-11 |
Pfizer Ltd |
Therapeutic agents
|
GR851819B
(hu)
*
|
1984-08-17 |
1985-11-26 |
Wyeth John & Brother Ltd |
|
GB8421039D0
(en)
*
|
1984-08-17 |
1984-09-19 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
IL77843A
(en)
*
|
1985-02-11 |
1989-07-31 |
Syntex Inc |
Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them
|
EP0200524A3
(en)
*
|
1985-05-03 |
1987-06-16 |
Pfizer Limited |
Dihydropyridine calcium antagonists
|
DE3531498A1
(de)
*
|
1985-09-04 |
1987-03-05 |
Bayer Ag |
Dihydropyridin-2-hydroxyamine, verfahren zur herstellung und ihre verwendung in arzneimitteln
|
EP0225175A3
(en)
*
|
1985-11-28 |
1988-12-28 |
FISONS plc |
Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
|
DE3544211A1
(de)
*
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
IT1204460B
(it)
*
|
1986-02-20 |
1989-03-01 |
Glaxo Spa |
Derivati eterociclici
|
GB8608335D0
(en)
*
|
1986-04-04 |
1986-05-08 |
Pfizer Ltd |
Pharmaceutically acceptable salts
|
US4983740A
(en)
*
|
1986-08-04 |
1991-01-08 |
Adir Et Compagnie |
Process for 1,4-dihydropyridine compounds
|
FR2649395B1
(fr)
*
|
1989-07-04 |
1992-11-06 |
Adir |
Nouveau derive de la dihydro-1,4 pyridine denomme (-) i1(((amino-2 ethoxy)-2 ethoxy) methyli1) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent
|
FR2602231B1
(fr)
*
|
1986-08-04 |
1988-10-28 |
Adir |
Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
US5196410A
(en)
*
|
1986-10-31 |
1993-03-23 |
Pfizer Inc. |
Transdermal flux enhancing compositions
|
IT1213555B
(it)
*
|
1986-12-11 |
1989-12-20 |
Boehringer Biochemia Srl |
2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
|
JPS63196564A
(ja)
*
|
1987-02-10 |
1988-08-15 |
Agency Of Ind Science & Technol |
イミドオリゴマ−の製造方法
|
IT1215381B
(it)
*
|
1987-03-12 |
1990-02-08 |
Boehringer Biochemia Srl |
Farmaceutiche che le contengono. carbonil- e solfonil- derivati di 2-(aminoalchiltio)metil-1,4-diidropiridine, un metodo per la loro preparazione e composizioni
|
GB8709447D0
(en)
*
|
1987-04-21 |
1987-05-28 |
Pfizer Ltd |
Dihydropyridines
|
GB8710493D0
(en)
*
|
1987-05-02 |
1987-06-03 |
Pfizer Ltd |
Dihydropyridines
|
DE3906406C1
(hu)
*
|
1989-03-01 |
1990-10-25 |
Goedecke Ag, 1000 Berlin, De |
|
US5234943A
(en)
*
|
1989-04-13 |
1993-08-10 |
Bayer Aktiengesellschaft |
Fungicidal 3-(2-chloro-3-trifluoromethylphenyl)-4-cyanopyrrole
|
DE4128132A1
(de)
*
|
1991-08-24 |
1993-02-25 |
Bayer Ag |
3-(2-chlor-3-trifluormethylphenyl)-4-cyanopyrrol, dessen herstellung und verwendung und neue zwischenprodukte
|
FR2652083B1
(fr)
*
|
1989-09-20 |
1992-01-24 |
Ador Cie |
Nouveau procede de separation d'isomeres optiques des derives de la dihydro-1,4 pyridine.
|
US5270323A
(en)
*
|
1990-05-31 |
1993-12-14 |
Pfizer Inc. |
Method of treating impotence
|
US6057344A
(en)
|
1991-11-26 |
2000-05-02 |
Sepracor, Inc. |
Methods for treating hypertension, and angina using optically pure (-) amlodipine
|
EP0661970A1
(en)
*
|
1991-11-26 |
1995-07-12 |
Sepracor, Inc. |
Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
|
US6162802A
(en)
*
|
1992-03-10 |
2000-12-19 |
Papa; Joseph |
Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
|
EP1614420A3
(en)
*
|
1992-11-25 |
2006-04-19 |
Sepracor Inc. |
Treatment of hypertension, angina and other disorders using (-) amlodipine
|
SI9200344B
(sl)
*
|
1992-11-26 |
1998-06-30 |
Lek, |
Postopek za pripravo amlodipin benzensulfonata
|
US5389654A
(en)
*
|
1992-11-26 |
1995-02-14 |
Lek, Tovarna, Farmacevtskih In Kemicnih . . . |
3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
|
US6221335B1
(en)
*
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
DE69626958T2
(de)
|
1995-03-16 |
2004-03-18 |
Pfizer Inc. |
Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz
|
NZ280378A
(en)
*
|
1995-11-01 |
1998-04-27 |
Apotex Inc |
4-phenyl-1,4-dihydropyridine-3,5-dicarboxylic acid compounds, preparation, intermediate compounds
|
HU221810B1
(hu)
*
|
1997-08-12 |
2003-01-28 |
EGIS Gyógyszergyár Rt. |
Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
|
GT199800127A
(es)
*
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
ZA9810320B
(en)
*
|
1997-11-14 |
2000-05-11 |
Gea Farmaceutisk Fabrik As |
Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
|
ZA9810319B
(en)
*
|
1997-11-14 |
2000-05-11 |
Gea Farmaceutisk Fabrik As |
Process for the preparation of acetal derivatives of 1,4-dihydropyridines, novel acetal derivatives and the use of the acetal derivatives for the preparation of other 1,4-dihydropyridines.
|
ES2151850B1
(es)
*
|
1998-10-26 |
2001-08-16 |
Esteve Quimica Sa |
Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
|
HN2000000050A
(es)
|
1999-05-27 |
2001-02-02 |
Pfizer Prod Inc |
Sal mutua de amlodipino y atorvastatina
|
JP2003500487A
(ja)
|
1999-05-27 |
2003-01-07 |
ファイザー・プロダクツ・インク |
アムロジピンおよびアトルバスタチンの共通プロドラッグ
|
UA72768C2
(en)
*
|
1999-07-05 |
2005-04-15 |
Richter Gedeon Vegyeszet |
A method for obtaining amilodipine benzenesulphonate
|
CN1091441C
(zh)
*
|
1999-12-04 |
2002-09-25 |
昆明赛诺制药有限公司 |
甲磺酸氨氯地平及其制法和应用
|
US6521647B2
(en)
|
2000-04-04 |
2003-02-18 |
Pfizer Inc. |
Treatment of renal disorders
|
ATE363281T1
(de)
*
|
2000-04-11 |
2007-06-15 |
Sankyo Co |
Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten
|
WO2003079972A2
(en)
|
2002-02-22 |
2003-10-02 |
New River Parmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
AU2001284413A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Sankyo Company Limited |
Medicinal compositions for preventing or treating heart failure
|
US6737430B2
(en)
|
2000-11-09 |
2004-05-18 |
Pfizer, Inc. |
Mutual prodrug of amlodipine and atorvastatin
|
GB0027410D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Pfizer Ltd |
Mutual prodrug of amlodipine and atorvastatin
|
ATE315026T1
(de)
*
|
2000-12-29 |
2006-02-15 |
Pfizer Ltd |
Amlodipin-hemimaleat
|
EP1309556B1
(en)
|
2000-12-29 |
2004-11-24 |
Pfizer Limited |
Amlodipine fumarate
|
OA13133A
(en)
*
|
2000-12-29 |
2006-12-13 |
Pfizer Ltd |
Process for making amlodipine maleate.
|
WO2002053541A1
(en)
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Amide derivative of amlodipine
|
AP2003002820A0
(en)
|
2000-12-29 |
2003-06-30 |
Pfizer Ltd |
"Process for making amlodipine maleate"
|
AT5874U1
(de)
|
2000-12-29 |
2003-01-27 |
Bioorg Bv |
Pharmazeutische zubereitungen enthaltend amlodipinmaleat
|
US7335380B2
(en)
|
2000-12-29 |
2008-02-26 |
Synthon Ip Inc. |
Amlodipine free base
|
MXPA03005882A
(es)
|
2000-12-29 |
2005-04-19 |
Pfizer Ltd |
Derivado amida de amlodipina.
|
US6653481B2
(en)
*
|
2000-12-29 |
2003-11-25 |
Synthon Bv |
Process for making amlodipine
|
EP1309558A1
(en)
|
2000-12-29 |
2003-05-14 |
Synthon Licensing, Ltd. |
Aspartate derivative of amlodipine as calcium channel antagonist
|
CA2433284A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Reference standards and processes for determining the purity or stability of amlodipine maleate
|
WO2002053535A2
(en)
*
|
2000-12-29 |
2002-07-11 |
Bioorganics B.V. |
Process for making amlodipine, derivatives thereof, and precursors therefor
|
KR100374767B1
(ko)
*
|
2001-03-13 |
2003-03-03 |
한미약품공업 주식회사 |
개선된 암로디핀의 제조 방법
|
KR100452491B1
(ko)
*
|
2001-03-29 |
2004-10-12 |
한미약품 주식회사 |
신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
|
DE60235101D1
(de)
*
|
2001-07-06 |
2010-03-04 |
Lek Pharmaceuticals |
Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
|
GB0120808D0
(en)
*
|
2001-08-28 |
2001-10-17 |
Pfizer Ltd |
Crystalline material
|
US6680334B2
(en)
|
2001-08-28 |
2004-01-20 |
Pfizer Inc |
Crystalline material
|
US20040001886A1
(en)
*
|
2001-10-17 |
2004-01-01 |
Dr. Reddy's Laboratories Limited |
Stabilized pharmaceutical formulations containing amlodipine maleate
|
US20030180354A1
(en)
*
|
2001-10-17 |
2003-09-25 |
Dr. Reddy's Laboratories Limited |
Amlodipine maleate formulations
|
US6562983B1
(en)
*
|
2002-03-18 |
2003-05-13 |
Council Of Scientific And Industrial Research |
Process for the preparation of alkyl 4[2-(phthalimido)ethoxy]-acetoacetate
|
US20070135488A1
(en)
*
|
2002-04-13 |
2007-06-14 |
Chung You S |
Amlodipine nicotinate and process for the preparation thereof
|
US6699892B2
(en)
|
2002-06-04 |
2004-03-02 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salt of amlodipine and method of preparing the same
|
KR100538641B1
(ko)
*
|
2002-07-30 |
2005-12-22 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100496436B1
(ko)
|
2002-07-30 |
2005-06-20 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR20040011751A
(ko)
*
|
2002-07-30 |
2004-02-11 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100462304B1
(ko)
|
2002-07-30 |
2004-12-17 |
씨제이 주식회사 |
암로디핀의 유기산염
|
ES2362998T3
(es)
|
2002-08-19 |
2011-07-18 |
Pfizer Inc. |
Terapia de combinación para enfermedades hiperproliferativas.
|
KR100467669B1
(ko)
*
|
2002-08-21 |
2005-01-24 |
씨제이 주식회사 |
암로디핀의 유기산염
|
US6784297B2
(en)
*
|
2002-09-04 |
2004-08-31 |
Kopran Limited |
Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
|
WO2004024690A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Hanlim Pharmaceutical Co., Ltd. |
S-(-)-amlodipine nicotinate and process for the preparation thereof
|
KR100596369B1
(ko)
|
2002-09-19 |
2006-07-03 |
씨제이 주식회사 |
결정형의 암로디핀 유기산염
|
AU2003253460A1
(en)
|
2002-09-19 |
2004-04-08 |
Cj Corporation |
Crystalline organic acid salt of amlodipine
|
US20040072879A1
(en)
*
|
2002-10-10 |
2004-04-15 |
Dr. Reddy's Laboratories Limited |
Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
|
AU2002368531A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. |
Isolation of dihydropyridine derivative and preparation salts thereof
|
DE10335027A1
(de)
*
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Angiotensin II Rezeptor Antagonisten
|
EP3045174A1
(en)
*
|
2003-01-31 |
2016-07-20 |
Daiichi Sankyo Company, Limited |
Medicine for prevention of and treatment for arteriosclerosis and hypertension
|
CA2559670A1
(en)
*
|
2003-04-14 |
2004-10-28 |
Gabor Pragai |
Stable amlodipine maleate formulations
|
WO2004093813A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
|
WO2004093816A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
|
WO2004096770A1
(en)
*
|
2003-04-25 |
2004-11-11 |
Cipla Limited |
Process for preparing almodipine mesylate monohydrate
|
JP2007500219A
(ja)
*
|
2003-05-16 |
2007-01-11 |
アンビット バイオサイエンシス コーポレーション |
複素環化合物およびその使用法
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
MXPA05012900A
(es)
*
|
2003-05-30 |
2006-02-22 |
Ranbaxy Lab Ltd |
Derivados de pirrol sustituidos.
|
CA2532807A1
(en)
*
|
2003-07-17 |
2005-02-03 |
Cotherix, Inc. |
Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
|
US20050037063A1
(en)
*
|
2003-07-21 |
2005-02-17 |
Bolton Anthony E. |
Combined therapies
|
CH697952B1
(de)
*
|
2003-07-25 |
2009-03-31 |
Siegfried Generics Int Ag |
Verfahren zur Reinigung der freien Amlodipinbase.
|
WO2005023769A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Cipla Limited |
Process for the preparation of amlodipine salts
|
AU2004272078A1
(en)
*
|
2003-09-10 |
2005-03-24 |
Synta Pharmaceuticals Corp. |
Dihydropyridine compounds for treating or preventing metabolic disorders
|
KR100841409B1
(ko)
|
2003-12-16 |
2008-06-25 |
에스케이케미칼주식회사 |
암로디핀 겐티세이트 염과 이의 제조방법
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
US20060030602A1
(en)
*
|
2004-03-16 |
2006-02-09 |
Sepracor Inc. |
(S)-amlodipine malate
|
US7244765B2
(en)
*
|
2004-06-25 |
2007-07-17 |
Cytokine Pharmasciences, Inc |
Guanylhydrazone salts, compositions, processes of making and methods of using
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
WO2006003672A1
(en)
*
|
2004-07-02 |
2006-01-12 |
Matrix Laboratories Ltd |
Process for the preparation of pure amlodipine
|
CA2574958A1
(en)
*
|
2004-07-26 |
2006-02-09 |
Cotherix, Inc. |
Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
|
EP1814527B2
(en)
*
|
2004-11-05 |
2020-11-18 |
Boehringer Ingelheim International GmbH |
Bilayer tablet comprising telmisartan and amlodipine
|
CA2590533C
(en)
*
|
2004-11-23 |
2010-09-07 |
Warner-Lambert Company Llc |
7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
|
EP1833466A1
(en)
*
|
2004-12-28 |
2007-09-19 |
Ranbaxy Laboratories Limited |
Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine
|
US20080268049A1
(en)
*
|
2005-02-11 |
2008-10-30 |
Dhaliwal Mona |
Stable Solid Dosage Forms of Amlodipine and Benazepril
|
CA2613417C
(en)
*
|
2005-06-27 |
2011-11-29 |
Daiichi Sankyo Company, Limited |
Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
|
AU2006264407B2
(en)
*
|
2005-07-04 |
2012-08-30 |
Ramu Krishnan |
Improved drug or pharmaceutical compounds and a preparation thereof
|
ES2265781B1
(es)
*
|
2005-08-04 |
2007-12-01 |
Ercros Industrial, S.A. |
Procedimiento para la obtencion de besilato de amlodipina.
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
EP2351569B1
(en)
|
2005-10-26 |
2012-08-22 |
Asahi Kasei Pharma Corporation |
Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
|
US7893050B2
(en)
*
|
2005-10-26 |
2011-02-22 |
Asahi Kasei Pharma Corporation |
Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
|
CA2627599A1
(en)
*
|
2005-11-08 |
2007-05-18 |
Ranbaxy Laboratories Limited |
Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
TW200806648A
(en)
*
|
2005-11-29 |
2008-02-01 |
Sankyo Co |
Acid addition salts of dihydropyridine derivatives
|
TW200736245A
(en)
*
|
2005-11-29 |
2007-10-01 |
Sankyo Co |
Acid addition salts of optically active dihydropyridine derivatives
|
US7919506B2
(en)
|
2006-03-10 |
2011-04-05 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
TW200744583A
(en)
*
|
2006-03-14 |
2007-12-16 |
Ranbaxy Lab Ltd |
Statin stabilizing dosage formulations
|
US20070260065A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Vijayabhaskar Bolugoddu |
Process for preparing amlodipine
|
BRPI0714361A2
(pt)
*
|
2006-07-14 |
2013-03-26 |
Ranbaxy Lab Ltd |
polimorfo cristalino, composiÇço farmacÊutica contendo o mesmo, mÉtodo para sua preparaÇço e mÉtodo de tratamento
|
WO2008023869A1
(en)
*
|
2006-08-24 |
2008-02-28 |
Hanall Pharmaceutical Co., Ltd. |
Combined pharmeceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
|
TWI399223B
(zh)
*
|
2006-09-15 |
2013-06-21 |
Daiichi Sankyo Co Ltd |
奧美沙坦酯及氨氯地平之固體劑型
|
US20080096863A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Torrent Pharmaceuticals Limited |
Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor
|
CN101167724B
(zh)
*
|
2006-10-25 |
2012-08-22 |
北京华安佛医药研究中心有限公司 |
含有氨氯地平的药物组合物在制备治疗下尿路疾病药物中的用途
|
KR100830003B1
(ko)
|
2006-10-31 |
2008-05-15 |
씨제이제일제당 (주) |
결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법
|
GB0624090D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril amine salts
|
GB0624084D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril amino acid salts
|
GB0624087D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril combination salt
|
EP2094643B1
(en)
|
2006-12-01 |
2012-02-29 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
CL2008000070A1
(es)
*
|
2007-01-17 |
2008-07-25 |
Lg Life Sciences Ltd |
Monosal del acido maleico (3-[({1-[(2-amino-9h-purin-9-il)metil]ciclopropil}oxi)metil]-8,8-dimetil-3,7-dioxo-2,4,6-trioxa-3 lambda 5-fosfanon-1-il-pivalato; composicion farmaceutica que comprende a dicha monosal; y uso para el tratamiento del virus h
|
CN101230035B
(zh)
*
|
2007-03-23 |
2010-11-03 |
浙江尖峰药业有限公司 |
门冬氨酸氨氯地平系列盐及其制备方法和其组合物、制剂以及片剂
|
EP1975167A1
(en)
*
|
2007-03-30 |
2008-10-01 |
Esteve Quimica, S.A. |
Acetone solvate of phthaloyl amlodipine
|
US20080249141A1
(en)
*
|
2007-04-06 |
2008-10-09 |
Palepu Nageswara R |
Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters
|
US20090062352A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched amlodipine
|
WO2009032286A2
(en)
|
2007-09-06 |
2009-03-12 |
Nektar Therapeutics Al, Corporation |
Oligomer-calcium channel blocker conjugates
|
UY31531A1
(es)
*
|
2007-12-17 |
2009-08-03 |
|
Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
|
JP2011507973A
(ja)
*
|
2007-12-31 |
2011-03-10 |
ルピン・リミテッド |
アムロジピンとバルサルタンとの医薬組成物
|
WO2009113420A1
(ja)
|
2008-03-13 |
2009-09-17 |
第一三共株式会社 |
オルメサルタンメドキソミルを含む製剤の溶出性の改善
|
CN101560181B
(zh)
*
|
2008-04-16 |
2013-02-27 |
北京万全阳光医学技术有限公司 |
一种氨氯地平游离碱的制备方法
|
CN101367759B
(zh)
*
|
2008-10-06 |
2011-03-16 |
北京赛科药业有限责任公司 |
一种高纯度苯磺酸氨氯地平的合成方法
|
JP2010100562A
(ja)
*
|
2008-10-23 |
2010-05-06 |
Daito Kk |
アムロジピン製造中間体の精製方法
|
JP2012528799A
(ja)
|
2009-06-02 |
2012-11-15 |
ダウ グローバル テクノロジーズ エルエルシー |
徐放製剤
|
WO2011071995A2
(en)
|
2009-12-08 |
2011-06-16 |
Case Western Reserve University |
Compounds and methods of treating ocular disorders
|
WO2011117876A1
(en)
|
2010-03-26 |
2011-09-29 |
Fdc Limited |
An improved process for the preparation of amlodipine free base and acid addition salts thereof
|
IT1400309B1
(it)
*
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
|
WO2011149438A1
(en)
|
2010-05-28 |
2011-12-01 |
Mahmut Bilgic |
Combination of antihypertensive agents
|
EP2575757A1
(en)
|
2010-06-03 |
2013-04-10 |
Mahmut Bilgic |
Water soluble formulation comprising a combination of amlodipine and a statin
|
WO2012037665A1
(en)
|
2010-09-24 |
2012-03-29 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
|
EP2632438A1
(en)
|
2010-10-27 |
2013-09-04 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Multilayer pharmaceutical composition comprising telmisartan and amlodipine
|
TR201100152A2
(tr)
|
2011-01-06 |
2012-07-23 |
Bi̇lgi̇ç Mahmut |
Amlodipin içeren efervesan bileşimler.
|
CN102070516A
(zh)
*
|
2011-02-22 |
2011-05-25 |
广东东阳光药业有限公司 |
一种制备氨氯地平的方法
|
WO2012123966A1
(en)
|
2011-03-04 |
2012-09-20 |
Arch Pharmalabs Limited |
Process for the preparation of 4 -substituted -1, 4-dihydropyridines
|
CA2832758C
(en)
|
2011-04-12 |
2015-12-15 |
Boryung Pharmaceutical Co., Ltd. |
Antihypertensive pharmaceutical composition
|
US9446032B2
(en)
|
2011-08-26 |
2016-09-20 |
Wockhardt Limited |
Methods for treating cardiovascular disorders
|
CN102382041B
(zh)
*
|
2011-12-02 |
2016-01-20 |
东北制药集团股份有限公司 |
一种马来酸氨氯地平的制备方法
|
PL236001B1
(pl)
|
2012-12-21 |
2020-11-30 |
Adamed Spolka Z Ograniczona Odpowiedzialnoscia |
Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
|
CN103044314A
(zh)
*
|
2013-01-06 |
2013-04-17 |
先声药业有限公司 |
马来酸氨氯地平的制备方法
|
JP5952748B2
(ja)
*
|
2013-01-25 |
2016-07-13 |
東和薬品株式会社 |
フタロイルアムロジピンの新規結晶形態およびそれを用いる高純度なアムロジピンベシル酸塩の製造方法
|
US20150374713A1
(en)
|
2013-02-08 |
2015-12-31 |
Wockhardt Limited |
Stable pharmeceutical composition of amlodipine and benazepril or salts thereof
|
EP2986599A1
(en)
|
2013-04-17 |
2016-02-24 |
Pfizer Inc. |
N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
|
ES2847904T3
(es)
|
2013-07-23 |
2021-08-04 |
Daiichi Sankyo Co Ltd |
Medicamento para la prevención o el tratamiento de la hipertensión
|
CN104262237A
(zh)
*
|
2014-09-28 |
2015-01-07 |
常州瑞明药业有限公司 |
氨氯地平自由碱的合成方法
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
CN104529877A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-癸酸离子液体及其制备方法和用途
|
CZ2015687A3
(cs)
|
2015-10-02 |
2017-04-12 |
Zentiva, K.S. |
Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu
|
US20180303811A1
(en)
|
2015-10-23 |
2018-10-25 |
Ftf Pharma Private Limited |
Oral solution of dihydropyridine derivatives
|
JP6934859B2
(ja)
|
2016-03-24 |
2021-09-15 |
第一三共株式会社 |
腎疾患の治療のための医薬
|
EP3463309B1
(en)
|
2016-05-30 |
2020-06-17 |
Boehringer Ingelheim International GmbH |
Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
|
ES2886067T3
(es)
|
2016-10-07 |
2021-12-16 |
Silvergate Pharmaceuticals Inc |
Formulaciones de amlodipina
|
US10350171B2
(en)
|
2017-07-06 |
2019-07-16 |
Dexcel Ltd. |
Celecoxib and amlodipine formulation and method of making the same
|
US10799453B2
(en)
|
2018-04-11 |
2020-10-13 |
Silvergate Pharmaceuticals, Inc. |
Amlodipine formulations
|
JP7470647B2
(ja)
*
|
2018-06-14 |
2024-04-18 |
アストラゼネカ・ユーケイ・リミテッド |
ジヒドロピリジン型カルシウムチャネル遮断薬医薬組成物を用いて血圧を低下させるための方法
|
CA3103679A1
(en)
|
2018-06-14 |
2019-12-19 |
Astrazeneca Uk Limited |
Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
|
EP3911648A4
(en)
|
2019-01-18 |
2022-10-26 |
Astrazeneca AB |
PCSK9 INHIBITORS AND METHODS OF USE THEREOF
|
AU2020278825A1
(en)
|
2019-05-21 |
2021-10-21 |
Société des Produits Nestlé S.A. Entre-deux-Villes 1800 Vevey Switzerland |
Dietary butyrate
|
GB2595203A
(en)
|
2020-03-03 |
2021-11-24 |
Alkaloid Ad Skopje |
Formulation
|
GB202102575D0
(en)
|
2021-02-23 |
2021-04-07 |
Teva Pharmaceutical Industries Ltd |
Fixed-dose pharmaceutical compositions
|